Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML

Clinical trial NCT00382954 · COMPLETED

Trial details

NCT number: NCT00382954
Sponsor: University of Kentucky
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2004-02-01
Primary completion: 2008-10-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.